Literature DB >> 11950191

Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia?

Rani Nagrani1, Peter Bowen-Simpkins, Julian W Barrington.   

Abstract

Menorrhagia is a common gynaecological condition for which medical treatment is often ineffective and a large number of women undergo major surgery. Previous short term studies have shown a significant number of women with menstrual problems may avoid surgery if a levonorgestrel intrauterine system (LNG-IUS) is fitted but no long term studies exist to ascertain if this benefit is sustained. This four to five year long term follow up study showed 50% of women continued to use the device and 67.4% avoided surgery. The LNG-IUS is well accepted and effective in the management of menorrhagia and has major cost implications to the National Health Service.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950191     DOI: 10.1111/j.1471-0528.2002.01274.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  3 in total

Review 1.  Benefits and risks of pharmacological agents used for the treatment of menorrhagia.

Authors:  Samendra Nath Roy; Siladitya Bhattacharya
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 2.  Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis.

Authors:  Jin Qiu; Jiajing Cheng; Qingying Wang; Jie Hua
Journal:  Med Sci Monit       Date:  2014-09-23

3.  Comparison of levonorgestrel-releasing intrauterine device with oral progestins in heavy menstrual bleeding (HMB) cases with uterine leiomyoma (LNG-IUD and oral progestin usage in myoma uteri).

Authors:  Ayse Kavasoglu Tosun; Ismet Tosun; Necdet Suer
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.